
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Karl D. Brune, Darren B. Leneghan, Iona J. Brian, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 373
Karl D. Brune, Darren B. Leneghan, Iona J. Brian, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 373
Showing 1-25 of 373 citing articles:
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mona O. Mohsen, Lisha Zha, Gustavo Cabral‐Miranda, et al.
Seminars in Immunology (2017) Vol. 34, pp. 123-132
Closed Access | Times Cited: 482
Mona O. Mohsen, Lisha Zha, Gustavo Cabral‐Miranda, et al.
Seminars in Immunology (2017) Vol. 34, pp. 123-132
Closed Access | Times Cited: 482
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu E. Lee, et al.
Science (2021) Vol. 371, Iss. 6530, pp. 735-741
Open Access | Times Cited: 390
Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu E. Lee, et al.
Science (2021) Vol. 371, Iss. 6530, pp. 735-741
Open Access | Times Cited: 390
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 251
Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 251
Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
Theodora U. J. Bruun, Anne‐Marie Andersson, Simon J. Draper, et al.
ACS Nano (2018) Vol. 12, Iss. 9, pp. 8855-8866
Open Access | Times Cited: 235
Theodora U. J. Bruun, Anne‐Marie Andersson, Simon J. Draper, et al.
ACS Nano (2018) Vol. 12, Iss. 9, pp. 8855-8866
Open Access | Times Cited: 235
Bioengineering bacterial outer membrane vesicles as vaccine platform
Matthias J. H. Gerritzen, Dirk E. Martens, René H. Wijffels, et al.
Biotechnology Advances (2017) Vol. 35, Iss. 5, pp. 565-574
Open Access | Times Cited: 234
Matthias J. H. Gerritzen, Dirk E. Martens, René H. Wijffels, et al.
Biotechnology Advances (2017) Vol. 35, Iss. 5, pp. 565-574
Open Access | Times Cited: 234
Engineering virus-like particles as vaccine platforms
Kathryn M. Frietze, David S. Peabody, Bryce Chackerian
Current Opinion in Virology (2016) Vol. 18, pp. 44-49
Open Access | Times Cited: 203
Kathryn M. Frietze, David S. Peabody, Bryce Chackerian
Current Opinion in Virology (2016) Vol. 18, pp. 44-49
Open Access | Times Cited: 203
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 199
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 199
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Susan Thrane, Christoph M. Janitzek, Sungwa Matondo, et al.
Journal of Nanobiotechnology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 183
Susan Thrane, Christoph M. Janitzek, Sungwa Matondo, et al.
Journal of Nanobiotechnology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 183
Protein-based antigen presentation platforms for nanoparticle vaccines
Brian Nguyen, Niraj H. Tolia
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 173
Brian Nguyen, Niraj H. Tolia
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 173
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Amelia Escolano, Harry B. Gristick, Morgan E. Abernathy, et al.
Nature (2019) Vol. 570, Iss. 7762, pp. 468-473
Open Access | Times Cited: 170
Amelia Escolano, Harry B. Gristick, Morgan E. Abernathy, et al.
Nature (2019) Vol. 570, Iss. 7762, pp. 468-473
Open Access | Times Cited: 170
Power to the protein: enhancing and combining activities using the Spy toolbox
Anthony H. Keeble, Mark Howarth
Chemical Science (2020) Vol. 11, Iss. 28, pp. 7281-7291
Open Access | Times Cited: 143
Anthony H. Keeble, Mark Howarth
Chemical Science (2020) Vol. 11, Iss. 28, pp. 7281-7291
Open Access | Times Cited: 143
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Raquel Cid, Jorge Bolı́var
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1072-1072
Open Access | Times Cited: 119
Raquel Cid, Jorge Bolı́var
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1072-1072
Open Access | Times Cited: 119
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 106
Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 106
Protein Cages: From Fundamentals to Advanced Applications
Thomas G. W. Edwardson, Mikail D. Levasseur, Stephan Tetter, et al.
Chemical Reviews (2022) Vol. 122, Iss. 9, pp. 9145-9197
Closed Access | Times Cited: 97
Thomas G. W. Edwardson, Mikail D. Levasseur, Stephan Tetter, et al.
Chemical Reviews (2022) Vol. 122, Iss. 9, pp. 9145-9197
Closed Access | Times Cited: 97
Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 87
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 87
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens
Kevin B. Weyant, Ayomide Oloyede, Sukumar Pal, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Kevin B. Weyant, Ayomide Oloyede, Sukumar Pal, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
Magnus A. G. Hoffmann, Zhi Yang, Kathryn E. Huey‐Tubman, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2380-2391.e9
Open Access | Times Cited: 45
Magnus A. G. Hoffmann, Zhi Yang, Kathryn E. Huey‐Tubman, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2380-2391.e9
Open Access | Times Cited: 45
Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 19
Rory A. Hills, Tiong Kit Tan, Alexander A. Cohen, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 8, pp. 1216-1223
Open Access | Times Cited: 19
Evolving Accelerated Amidation by SpyTag/SpyCatcher to Analyze Membrane Dynamics
Anthony H. Keeble, Anusuya Banerjee, Matteo P. Ferla, et al.
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 52, pp. 16521-16525
Open Access | Times Cited: 161
Anthony H. Keeble, Anusuya Banerjee, Matteo P. Ferla, et al.
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 52, pp. 16521-16525
Open Access | Times Cited: 161
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
Mona O. Mohsen, Ariane C. Gomes, Monique Vogel, et al.
Vaccines (2018) Vol. 6, Iss. 3, pp. 37-37
Open Access | Times Cited: 158
Mona O. Mohsen, Ariane C. Gomes, Monique Vogel, et al.
Vaccines (2018) Vol. 6, Iss. 3, pp. 37-37
Open Access | Times Cited: 158
New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue
Karl D. Brune, Mark Howarth
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 137
Karl D. Brune, Mark Howarth
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 137
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
Wei‐Chiao Huang, Bingbing Deng, Cuiyan Lin, et al.
Nature Nanotechnology (2018) Vol. 13, Iss. 12, pp. 1174-1181
Open Access | Times Cited: 132
Wei‐Chiao Huang, Bingbing Deng, Cuiyan Lin, et al.
Nature Nanotechnology (2018) Vol. 13, Iss. 12, pp. 1174-1181
Open Access | Times Cited: 132
Escherichia coli-derived virus-like particles in vaccine development
Xiaofen Huang, Xin Wang, Jun Zhang, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 129
Xiaofen Huang, Xin Wang, Jun Zhang, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 129